Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2566 of 5804
-
Diabetes buddy system boosts Pill-Taking and Self-Care
Disease control CompletedThe goal of this interventional study is to learn about the effect of a peer support group intervention on adherence, self-care practice, and knowledge among diabetic patients on follow-up care. The main question it aims to answer is: * Does participation in a peer support group…
Phase: NA • Sponsor: Addis Ababa University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study aims to boost growth and health in kids with thalassemia
Disease control OngoingThere are nearly 300,000 patients with severe or intermediate thalassemia in China. Growth retardation is the most significant health issue for children and adolescents with transfusion-dependent thalassemia (TDT), placing a substantial economic burden on their families and a ser…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New rabies antibody shot tested in kids – could replace current treatment?
Prevention CompletedThis study is a randomized, double-blind, active-controlled design. The goal is to evaluate the safety, pharmacokinetics and pharmacodynamic of SYN023 in combination with rabies vaccine in healthy participants under 18 years of age. Participants will: 1. Be randomly assigned to…
Phase: PHASE1 • Sponsor: Synermore Biologics (Suzhou) Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Step up to surgery: daily walks may cut bladder cancer operation risks
Symptom relief Recruiting nowBladder cancer (BC) is the 6th most common tumor in Europe, with over 540,000 new cases globally each year. While 75% of cases are non-muscle-invasive and treated bladder-preservingly, muscle-invasive, non-metastatic BC requires radical cystectomy (RC), often with neoadjuvant che…
Phase: NA • Sponsor: Ludwig-Maximilians - University of Munich • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
A smarter filter for colostomy bags aims to end ballooning and odour
Symptom relief Recruiting nowThis 3-way crossover study aims to evaluate whether colostomy bags with an active chamber filter system reduce the incidence of filter-related complications, such as ballooning and pancaking, help neutralise odour, and minimise faecal leakage through the filter compared to colost…
Phase: NA • Sponsor: Salts Healthcare • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Mind over body: new film series aims to boost wellbeing in young cancer survivors
Symptom relief OngoingThe aim of this study is to assess whether a digital body mindset intervention - EMBody - can instil adaptive mindsets and improve health and wellbeing in young cancer survivors aged 16-25.
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Special blood storage could cut transfusions for cancer patients
Disease control Recruiting nowThe overall objective of this study is to collect preliminary effectiveness and safety data on the transfusion of hypoxic RBCs, manufactured with the Hemanext ONE device, in patients with hematological malignancies. The Hemanext ONE device received CE mark in April 2021.
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for hepatitis b? early trial of Tune-401 begins
Disease control Recruiting nowThis study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Tune-401 in adult participants with Chronic Hepatitis B.
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New group therapy shows promise for easing sensory overload in autistic teens
Symptom relief CompletedThe goal of this study is to assess whether a new psychological treatment can lead to changes in sensory experiences in autistic young people. Participants will complete a group intervention designed to help manage sensory difficulties and associated anxiety. Participants will al…
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New program aims to ease HIV stigma for expectant mothers in ghana
Knowledge-focused ENROLLING_BY_INVITATIONPurpose of this Study: The main purpose of this study is to adapt an existing evidence-based intervention, Project Accept Post-Test Support Services (PTSS) Module 3, specifically for pregnant and postpartum women living with HIV (WLWH) in Ghana. The adapted intervention aims to …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can a dedicated heart failure network improve outcomes after hospitalization?
Knowledge-focused Recruiting nowPEDAL-HF is a registry-based randomized prospective multicenter study. The investigators plan to include 1000 patients who were recently admitted with acute decompensated heart failure at five tertiary heart clinics in Germany. For the randomised part, 750 patients will be random…
Phase: NA • Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Ear-Zap device could curb teen Self-Harm
Prevention Recruiting nowNon-suicidal self-injury (NSSI) are acts defined by the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders 5) as intentional and deliberate, occurring outside a psychotic state and directly causing moderate injury. Their international prevalence is between 13 and 17% i…
Phase: NA • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
Avapritinib rollover trial aims to confirm Long-Term safety for mastocytosis patients
Disease control Recruiting nowThe primary objective of the rollover study is to evaluate the long-term safety of avapritinib in participants who have completed a Blueprint Medicines sponsored study (parent study) and continued to benefit from avapritinib.
Phase: PHASE4 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New eye drop shows promise for glaucoma control in chinese patients
Disease control OngoingThis is a Phase III Study that includes a single arm, open-label, multi-dose PK study cohort and a randomized, evaluator-masked, active drug-control multicenter study. Subjects diagnosed with POAG (Primary Open Angle Glaucoma) or OHT (Ocular Hypertension) who meet eligibility cr…
Phase: PHASE3 • Sponsor: Santen Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can finding purpose lift your mood? new study says yes
Symptom relief CompletedYoung adults with internalizing symptoms will be randomly assigned to a six-session meaning-centered intervention condition or a waitlist condition. Both conditions receive the same questionnaires at baseline, post assessment (intervention condition: immediately after the final s…
Phase: NA • Sponsor: University of Groningen • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Can online coaching help parents of preterm kids?
Disease control Recruiting nowMany children born very preterm experience behavior problems, and existing resources for parenting these children are lacking. A pilot trial established the effectiveness of a preterm parenting intervention, I-Interact Preterm (I2P). This study proposes a three-arm randomized con…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug combo aims to outsmart tough cancers
Disease control Recruiting nowThis is a phase I, open-label, multi-center, dose escalation and expansion study in advanced or metastatic solid tumor patients. The're are two goals set in this study: one is to explore the safety and tolerability of KGX101 when mono and combo with envafolimab in Chinese patient…
Phase: PHASE1 • Sponsor: Kangabio AUSTRALIA LTD PTY • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Shorter radiation may ease lung cancer treatment burden
Symptom relief OngoingThe SHiP-Rt Study aims to investigate the safety and efficacy of reducing the number of RT fractions and RT duration, compared to the current standard of care (36Gy in 12 fractions over 16 days), by using shortened hypofractionated accelerated palliative radiotherapy (30Gy in 6 a…
Phase: NA • Sponsor: University Hospitals Coventry and Warwickshire NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Brain training may help curb food cravings
Symptom relief Recruiting nowThis project tests whether individuals with overweight or obesity and high craving can learn to change their brain response to food cues using neurofeedback, to impact their craving and eating behavior.
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Could a simple ear device ease hEDS symptoms?
Symptom relief CompletedHypermobile EDS and hypermobile spectrum disorder (collectively referred to as hEDS) are estimated to affect 1 in 500 individuals worldwide. hEDS patients have limited treatment options for their numerous symptoms that impact the quality of life. This clinical trial tests a new e…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC